SUPN
SUPERNUS PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$42.00
−2.14%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- $0.61
- Revenue estimate
- $218.3M
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- $0.54
- EPS estimate
- $0.42
- Revenue actual
- $219.1M
- Revenue estimate
- $205.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -6376.1%
- Revenue beats (12Q)
- 8
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | $0.42 | $0.54 | Beat 27.81% | $219.1M |
| May 5, 2026 | $0.28 | $0.59 | Beat 110.71% | $207.7M |
| Feb 24, 2026 | $0.28 | -$72 | Miss -25666.26% | $211.6M |
| Nov 4, 2025 | $0.82 | $1.01 | Beat 23.17% | $192.1M |
| Feb 27, 2024 | $0.41 | $0.02 | Miss -95.12% | $164.3M |
| Nov 8, 2023 | $0.13 | -$0.29 | Miss -323.08% | $153.9M |
| Feb 28, 2023 | $0.68 | $0.43 | Miss -36.76% | $167.3M |
| Aug 4, 2022 | $0.29 | $0.14 | Miss -51.39% | $170.1M |
| Apr 13, 2022 | $0.24 | $0.04 | Miss -83.33% | $152.5M |
| Feb 28, 2022 | $0.24 | $0.04 | Miss -81.50% | $159.1M |
| Nov 3, 2021 | $0.23 | $0.40 | Beat 73.91% | $148.5M |
| Aug 4, 2021 | $0.20 | $0.43 | Beat 115.00% | $141.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026